Axerion Therapeutics rebranded as ReNetX Bio.
Spinal Tech
Tissue Regenix reported a proposed acquisition of CellRight Technologies.
Here are 12 key notes on orthopedic and spine device companies from the past week.
The global vertebroplasty and kyphoplasty market will expand, according to a Transparency Market Research report.
The global spinal cord stimulation market will grow at a compound annual growth rate of 9.2 percent through 2021, based on a Market Data Forecast report, according to medGadget.
Advertisement
According to Market Realist, Stryker saw an 18.5 percent year over year growth in the first quarter of 2017. The company is now looking to expand its interventional spine segment.
Premia Spine launched an FDA pivotal study of the TOPS system, and the first procedure was performed in Pennsylvania.
Five Considerations for Spine Surgeons When Evaluating Surface-Enhanced Interbody Fusion Devices for Optimal Clinical Outcomes from the Company that Wrote the Book
Simplify Medical closed a Series B financing round.
The North American spinal implants market will reach $7 billion by 2024, based on a Data Bridge Market Research report, according to medGadget.